|

Lenvatinib + Envafolimab Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • 3D Medicines (Sichuan) Co., Ltd.1

Indications

  • Liver Disease1
  • Renal Cell Carcinoma1
  • Solid Tumors1
  • Liver Cancer1
  • Hepatocellular Carcinoma1

Other1 trial

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.